Open in interactive viewer → charts, metric popovers & call review

Aveanna's $100 Million Quarter Comes With a California Asterisk

The rate increase management spent five years chasing just became a six-month supplemental payment — and the wage pass-through it promised has been quietly withdrawn
AVAH · Earnings Call · 2026-11-12

The milestone, and the guidance that doesn't assume a repeat

Aveanna crossed a line that mattered to it in the third quarter: adjusted EBITDA of $100.1 million on revenue of $695.5 million, up 25% and 11.8% respectively, with all three segments growing — Private Duty Services +11.6%, Home Health & Hospice +15.6%, Medical Solutions +9.1%. Management raised full-year guidance to greater than $2.695 billion of revenue and greater than $374 million of adjusted EBITDA. Total revenue has compounded 83% since 2020, and gross margin of 32.6%, down 3.2 points year over year, is the tell that this is a volume story dressed as a rate story. But the shape of the guidance is less triumphant than the headline. Strip out the low end and Q4 lands below Q3. Jeff Shaner did not hide it: “mid-90s is where we really have anchored to as a team, and we think it's prudent to guide in that manner” — Jeffrey Shaner, Chief Executive Officer · 2026-11-12 — pointing at three holiday weeks and the absence of last year's extra fiscal week. For a stock that has run 24.6% in ninety trading days and sits 14.9% below its 14 September peak of $14.38, a sequential guide-down is the kind of detail that decides whether the next leg is up.

California: the win that shrank

This is the real story of the quarter, and it is buried in the Q&A rather than the prepared remarks. Aveanna has spent five years lobbying Sacramento. SB 111 put roughly $30 million of state money into private duty nursing rates, matched by federal FMAP for a $60 million total. Management's expectation — telegraphed across at least three prior calls — was a re-based fee-for-service schedule, roughly a 40% increase to the PDN rate. What the Department of Health Care Services actually intends, per Shaner, is different in kind, not just in size:

instead of changing the fee-for-service schedule by the approximate 40% increase, they're intending to add a supplemental hourly payment on top of the current rate. We understand how they get there. We just vehemently disagree with their position as the department.

Jeffrey Shaner, Chief Executive Officer · 2026-11-12
A supplemental payment covering 1 January to 30 June 2027 is a grant. A permanent rate is an asset. Aveanna's entire growth model — the one underneath the raised 5-6% long-term PDS organic growth rate — is built on the second thing. And here is where it bites. In August, Matt Buckhalter promised the opposite of what he delivered this week. “We will be proactive. Once things settle... on passing through wages to really pull those patients out of the hospital” — Matthew Buckhalter, Chief Financial Officer · 2026-08-13, he said, with Jeff Shaner adding that “We will start passing wages through some point early to mid-October” — Jeffrey Shaner, Chief Executive Officer · 2026-08-13 and be "running at full speed" by December. On this call, that plan is gone: “we're just unable to invest meaningful dollars in base wage rates until we have certainty around the PDN rate investment” — Matt Buckhalter, Chief Financial Officer · 2026-11-12. The forfeited wage pre-investment is not a rounding error in the narrative — it is the mechanism. Buckhalter described the pattern for every other rate event as a "whiplash effect": the dam releases, hospital-stuck patients flow home, caregivers get hired. By refusing to prime the pump until permanence is legislated, Aveanna defers that volume surge into a 2028 budget fight with Governor-elect Becerra — a name that is itself brand new in the company's wage rate lexicon this quarter. The Governor Newsom to Becerra handoff is now the single largest swing factor in a $2.7 billion market-cap company's growth algorithm.

What management stopped saying

The keyword rotation is unusually clean. A year ago this quarter, the top keyword was Family First, the Florida acquisition that dominated two calls. This week it got one sentence — back-office integration "essentially" complete, wrap-up by year-end. Fair enough; it is done. But the other disappearance matters more. Rate wins spiked hard in late 2025 and is now among the company's sharpest keyword decliners: eight state rate enhancements year-to-date after ten in 2025, with Shaner guiding to six to eight next year, "more cost-of-living oriented." That is a decelerating engine being replaced by a volume engine that requires hiring, which requires the wage rate, which requires California. The offset is preferred payer execution, now the company's fifth-ranked theme. Thirty-eight PDS agreements against a goal of forty, with preferred payers at 65% of MCO volumes versus 57% at the end of 2025. Medical Solutions went from zero agreements two years ago to twenty-two. The phrase Medical Solutions is also showing up in the broader market's keyword set this quarter, suggesting the segment-level language is resonating beyond this one transcript. Home Health is the genuine bright spot and worth the ink: episodic agreement count of 52 — 51 of them Medicare Advantage — an 80% episodic mix, 19.6% admission growth and 24% episode growth. Shaner was refreshingly honest that it cannot last: “Do I think we can keep 20% to 25% organic growth going forever? No, I don't think that's sustainable forever.” — Jeffrey Shaner, Chief Executive Officer · 2026-11-12

The flywheel, and what funds it

The macro backdrop is not hostile. Post-midterm, recent elections came up and Shaner's read was measured — Democrats have historically invested deeper in Medicaid, several states flipped, Texas has maxed its rainy-day fund for four cycles — but "nothing that we would point out that says drastic change positively or negatively." One Big Beautiful Bill left PDN roughly untouched. That is a steady-state backdrop, not a tailwind. What funds all of this is a balance sheet that has genuinely transformed. Liquidity of $492 million, $1.52 billion of variable-rate debt effectively fully hedged through December 2029 after a new $880 million cap struck at 5.25%, and free cash flow of $141.2 million year-to-date. Effective net cash of negative $1.2 billion is still the constraint, and liabilities at 86.3% of assets is down from the 2024 peak. The stated target is sub-3x leverage in 2027, "as we do M&A" — which is the tension: the deleveraging story and the acquisition story are competing for the same cash. Valuation has already done much of the work. At 12.4x free cash flow, the shares are no longer a distressed option. They are a bet that California's $60 million becomes permanent, that the wage rate follows, and that the permanent rate unlocks the volume the preferred payer book is contractually set up to absorb. Q3 proved the operating machine works. Q4 will show whether management blinks on the wage pass-through — and the 2028 California budget, negotiated by a governor who was not in office when this fight started, is where the story gets settled.